T2 Biosystems Inc

TTOO.US
Healthcare · Diagnostics & Research
0.00
+0.00 (+150.00%)
USD · PINK

Company Information

Company Name
T2 Biosystems Inc
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
PINK
ISIN: US89853L1044
CIK: 0001492674
CUSIP: 89853L104
Currency: USD
Full Time Employees: 113
Phone: 781 761 4646
Fiscal Year End: December
IPO Date: Aug 07, 2014
Description:

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.

Address:

101 Hartwell Avenue, Lexington, MA, United States, 02421

People

Directors & Officers

Name Title Year Born
Mr. Craig R. Jalbert CIRA CEO, President, Corporate Treasurer, Corporate Secretary & Director 1962
Ms. Kelley J. Morgan Chief People Officer 1976
Mr. Brett A. Giffin Chief Commercial Officer 1959
Dr. Roger Smith Ph.D. Senior Vice President of Science Research & Development 1965

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 13, 2024 David B Elsbree N/A Sale 55.00 $2.42 $133.10

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Armistice Capital, LLC 1.40M Sep 30, 2024 4.98% $0.04 -15.80%
Vanguard Group Inc 390.37K Sep 30, 2024 1.39% $0.00 24.84%
Geode Capital Management, LLC 90.88K Sep 30, 2024 0.32% $0.00 -30.30%
BlackRock Inc 76.83K Sep 30, 2024 0.27% $0.00 -1.88%
State Street Corp 63.74K Sep 30, 2024 0.23% $0.00 0.00%
Susquehanna International Group, LLP 45.48K Sep 30, 2024 0.16% $0.00 9.16%
Millennium Management LLC 39.14K Sep 30, 2024 0.14% $0.00 0.00%
Northern Trust Corp 27.14K Sep 30, 2024 0.10% $0.00 -30.19%
Kingswood Wealth Advisors LLC 20.00K Dec 31, 2024 0.07% $0.00 0.00%
Goldman Sachs Group Inc 14.75K Sep 30, 2024 0.05% $0.00 0.31%
Royal Bank of Canada 4.00K Sep 30, 2024 0.01% $0.00 40.14%
Tower Research Capital LLC 2.40K Sep 30, 2024 0.01% $0.00 -68.71%
Group One Trading, LP 289.00 Sep 30, 2024 0.00% $0.00 -71.39%
Advisor Group Holdings, Inc. 205.00 Sep 30, 2024 0.00% $0.00 0.00%
Barclays PLC 101.00 Sep 30, 2024 0.00% $0.00 0.00%
International Assets Investment Management, LLC 65.00 Sep 30, 2024 0.00% $0.00 96.97%
Bank of America Corp 56.00 Sep 30, 2024 0.00% $0.00 -56.25%
Morgan Stanley - Brokerage Accounts 14.00 Sep 30, 2024 0.00% $0.00 -50.00%
U.S. Bancorp 3.00 Sep 30, 2024 0.00% $0.00 0.00%
UBS Group AG 1.00 Sep 30, 2024 0.00% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 154.81K 0.55% ▲ 0.00% Dec 31, 2024
2 Spartan Total Market Index Pool E 65.98K 0.24% ▲ 646.85% Dec 31, 2024
3 Extended Equity Market Fund K 40.54K 0.14% ▼ 1.36% Dec 31, 2024
4 Fidelity Extended Market Index 36.38K 0.13% ▼ 0.80% Dec 31, 2024
5 Fidelity Total Market Index 21.41K 0.08% ▲ 0.00% Dec 31, 2024
6 NT Ext Equity Mkt Idx Fd - L 16.11K 0.06% ▲ 0.00% Dec 31, 2024
7 Northern Trust Extended Eq Market Idx 16.11K 0.06% ▲ 0.00% Dec 31, 2024
8 NT Ext Equity Mkt Idx Fd - NL 10.63K 0.04% ▲ 0.00% Dec 31, 2024
9 Fidelity Nasdaq Composite Index 9.23K 0.03% ▲ 0.00% Dec 31, 2024
10 Fidelity Series Total Market Index 8.74K 0.03% ▲ 0.00% Dec 31, 2024

Financial Highlights

Market Cap: $5.61K
EBITDA: $-41.40M
PEG Ratio: $0.00
Book Value: $-0.62
Earnings/Share: $-0.03
Profit Margin: 0.00%
Operating Margin: -511.89%
ROA (TTM): -84.85%
ROE (TTM): -622.14%
Revenue (TTM): $7.68M
Revenue/Share (TTM): $0.73
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 34.90%

Valuation Metrics

Enterprise Value: $16.87M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 28.05M
Shares Float: 11.90M
% Insiders: 537.90%
% Institutions: 0.00%
Short % Float: 4.87%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$7.19M
Cost of Goods Sold
adjust
$-15.36M
Gross Profit
subtotal
$-8.17M
SG&A
adjust
$-26.13M
R&D
adjust
$-14.15M
Other Operating Expense
adjust
$-1.21M
Operating Income
subtotal
$-49.66M
Other / Non-Operating Items
adjust
$-413.00K
Net Income
subtotal
$-50.08M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TTOO.US!